Research tools
Analyst Ratings Screener
Find recent upgrades, downgrades, initiations, and reiterations by firm, rating, consensus, target upside, sector, and company size.
Save your best screens
Sign in to keep filters and sorting ready for your next visit.
3,896 matching rating changes
Export CSV| Date, sort lowest first | Symbol | Company | Firm | Action | Prior rating | New rating | Consensus | Analysts, sort highest first | Avg. target | Target upside, sort highest first | Market cap, sort highest first |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | SMTC | Semtech Corporation | Needham | Reiterated | Buy | Buy | — | — | $73.80 | -60.11% | 6.82B |
| Aug 26, 2026 | SMTC | Semtech Corporation | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $73.80 | -60.11% | 6.82B |
| Aug 26, 2026 | SNOW | Snowflake Inc. | Citigroup | Main | Buy | Buy | Buy | 39 | $282.25 | -15.09% | 73.81B |
| Aug 26, 2026 | SPCX | AXS SPAC and New Issue ETF | Wolfe Research | Reiterated | Outperform | Outperform | — | — | — | — | 8.9M |
| Aug 26, 2026 | SPGI | S&P Global Inc. | RBC Capital | Reiterated | Outperform | Outperform | Buy | 15 | $595.60 | +46.95% | 150.71B |
| Aug 26, 2026 | STRC | MicroStrategy Incorporated Variable Rate Series A Perpetual Stretch Preferred Stock | Bernstein | Main | Outperform | Outperform | Buy | 22 | $252.00 | +155.81% | 28.45B |
| Aug 26, 2026 | STRD | MicroStrategy Incorporated 10.00% Series A Perpetual Stride Preferred Stock | Bernstein | Main | Outperform | Outperform | Buy | 22 | $231.50 | +212.03% | 953.41M |
| Aug 26, 2026 | STRK | MicroStrategy Incorporated | Bernstein | Main | Outperform | Outperform | — | — | — | — | 25.3B |
| Aug 26, 2026 | SYRE | Spyre Therapeutics, Inc. | Wedbush | Main | Outperform | Outperform | — | — | $43.00 | -52.35% | 2.07B |
| Aug 26, 2026 | SYRE | Spyre Therapeutics, Inc. | BTIG | Main | Buy | Buy | — | — | $43.00 | -52.35% | 2.07B |
| Aug 26, 2026 | SYRE | Spyre Therapeutics, Inc. | Deutsche Bank | Main | Buy | Buy | — | — | $43.00 | -52.35% | 2.07B |
| Aug 26, 2026 | TEAM | Atlassian Corporation Class A Common Stock | RBC Capital | Initiated | — | Outperform | Buy | 22 | $232.85 | +21.26% | 42.84B |
| Aug 26, 2026 | TJX | The TJX Companies, Inc. | Jefferies | Downgrade | Buy | Hold | Buy | 18 | $165.91 | +30.39% | 173.16B |
| Aug 26, 2026 | TRUP | Trupanion, Inc. | Piper Sandler | Downgrade | Overweight | Neutral | — | — | $67.00 | +167.25% | 1.58B |
| Aug 26, 2026 | WAY | Waystar Holding Corp. | Needham | Reiterated | Buy | Buy | — | — | $47.60 | +85.50% | 5.63B |
| Aug 26, 2026 | WT | WisdomTree, Inc. | Oppenheimer | Main | Outperform | Outperform | — | — | $14.25 | -38.23% | 1.65B |
| Aug 26, 2026 | XPEV | XPeng Inc. | Barclays | Main | Underweight | Underweight | — | — | $29.00 | +173.07% | 18.23B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Citizens | Reiterated | Market Perform | Market Perform | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | RBC Capital | Reiterated | Outperform | Outperform | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Keybanc | Reiterated | Sector Weight | Sector Weight | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | BTIG | Reiterated | Buy | Buy | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Rosenblatt | Main | Buy | Buy | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Needham | Reiterated | Buy | Buy | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Cantor Fitzgerald | Reiterated | Neutral | Neutral | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Jefferies | Main | Buy | Buy | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZM | Zoom Communications, Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $92.89 | +4.64% | 27.35B |
| Aug 26, 2026 | ZS | Zscaler, Inc. | JP Morgan | Main | Overweight | Overweight | Buy | 56 | $320.60 | +62.49% | 37.73B |
| Aug 26, 2026 | ZYME | Zymeworks Inc. | HC Wainwright & Co. | Main | Buy | Buy | — | — | $32.00 | +20.44% | 1.88B |
| Aug 26, 2026 | ZYME | Zymeworks Inc. | Citigroup | Main | Buy | Buy | — | — | $32.00 | +20.44% | 1.88B |
| Aug 26, 2026 | ZYME | Zymeworks Inc. | Citizens | Reiterated | Market Outperform | Market Outperform | — | — | $32.00 | +20.44% | 1.88B |
| Aug 25, 2026 | ABT | Abbott Laboratories | TD Cowen | Main | Buy | Buy | Buy | 19 | $151.40 | +47.64% | 202.45B |
| Aug 25, 2026 | ACAD | ACADIA Pharmaceuticals Inc. | Morgan Stanley | Main | Equal-Weight | Equal-Weight | — | — | $28.00 | +2.60% | 4.16B |
| Aug 25, 2026 | ACAD | ACADIA Pharmaceuticals Inc. | Deutsche Bank | Main | Buy | Buy | — | — | $28.00 | +2.60% | 4.16B |
| Aug 25, 2026 | ACAD | ACADIA Pharmaceuticals Inc. | Citigroup | Main | Buy | Buy | — | — | $28.00 | +2.60% | 4.16B |
| Aug 25, 2026 | ACM | Aecom | Argus Research | Main | Buy | Buy | — | — | $140.67 | +126.92% | 12.67B |
| Aug 25, 2026 | ACN | Accenture plc | Wolfe Research | Main | Outperform | Outperform | Buy | 17 | $291.75 | +60.93% | 129.44B |
| Aug 25, 2026 | AGMB | AgomAb Therapeutics N.V. American Depositary Shares | Piper Sandler | Initiated | — | Overweight | — | — | — | — | 400.5K |
| Aug 25, 2026 | ALB | Albemarle Corporation | JP Morgan | Main | Neutral | Neutral | Hold | 31 | $114.13 | +2.90% | 21.06B |
| Aug 25, 2026 | AMAT | Applied Materials, Inc. | Mizuho | Main | Outperform | Outperform | Buy | 26 | $255.27 | -42.58% | 295.46B |
| Aug 25, 2026 | AMD | Advanced Micro Devices, Inc. | Raymond James | Upgrade | Outperform | Strong Buy | Buy | 35 | $295.24 | -47.26% | 326.42B |
| Aug 25, 2026 | AMRZ | Amrize Ltd | DA Davidson | Initiated | — | Neutral | Buy | 16 | $57.72 | +53.76% | 35.94B |
| Aug 25, 2026 | ANAB | AnaptysBio, Inc. | TD Cowen | Main | Buy | Buy | — | — | $54.20 | -1.81% | 1.52B |
| Aug 25, 2026 | AWI | Armstrong World Industries, Inc. | DA Davidson | Initiated | — | Buy | Buy | 14 | $205.75 | +28.89% | 8.09B |
| Aug 25, 2026 | AXS | AXIS Capital Holdings Limited | TD Cowen | Reiterated | Buy | Buy | — | — | $118.60 | +19.56% | 7.98B |
| Aug 25, 2026 | BEAM | Beam Therapeutics Inc. | HC Wainwright & Co. | Reiterated | Buy | Buy | — | — | $38.00 | +52.30% | 2.79B |
| Aug 25, 2026 | BEEM | Beam Global | Freedom Broker | Downgrade | Buy | Hold | Buy | 11 | $25.00 | +1793.94% | 31.02M |
| Aug 25, 2026 | BFH | Bread Financial Holdings, Inc. | Wolfe Research | Upgrade | Peer Perform | Outperform | — | — | $68.50 | -36.88% | 3.39B |
| Aug 25, 2026 | BIIB | Biogen Inc. | RBC Capital | Main | Outperform | Outperform | — | — | $177.00 | -17.87% | 25.33B |
| Aug 25, 2026 | BILL | Bill.com Holdings, Inc. | Wolfe Research | Main | Outperform | Outperform | — | — | $57.00 | +19.82% | 5.64B |
| Aug 25, 2026 | BKR | Baker Hughes Company | RBC Capital | Main | Outperform | Outperform | Buy | 13 | $53.14 | -7.18% | 46.84B |
